Meta-analysis: Selective serotonin reuptake inhibitors and colon cancer

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 10, 2012, Pages 1153-1157

  Lee, Hyun Ki ^a   Eom, Chun Sick ^b,c   Kwon, Young Min ^a   Ahn, Jeong Soo ^a   Kim, Sarah ^a   Park, Sang Min ^a  

^a Seoul National University Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

Author keywords

antidepressant; colon cancer; colorectal cancer; meta analysis; selective serotonin reuptake inhibitors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CANADA; CANCER LOCALIZATION; CANCER RISK; COLON CANCER; CORRELATION ANALYSIS; DENMARK; DISEASE ASSOCIATION; FINLAND; HUMAN; OBESITY; PRIORITY JOURNAL; TREATMENT DURATION; UNITED KINGDOM; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; COLORECTAL NEOPLASMS; HUMANS; ODDS RATIO; OVERWEIGHT; RISK; SEROTONIN UPTAKE INHIBITORS;

EID: 84866310239     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328355e289     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108. (Pubitemid 40372904)
2. Jemal A, Murray T, Samulels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26. (Pubitemid 36163619)
3. Rupnarain C, Dlamini Z, Naicker S, Bhoola K. Colon cancer: genomics and apoptotic events. Biol Chem 2004; 385:449-464. (Pubitemid 38967772)
4. Parkin DM, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. Eu J Cancer 2001; 37:4-66.
5. Brandes LJ, Arron RJ, Bogdanovic RP, Tong J, Zaborniak CL, Hoqq GR, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992; 52:3796-3800.
6. Tutton PJ, Barkla D. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 1982; 46:260.
7. Tutton P, Steel G. Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer 1979; 40:743.
8. Tutton PJ, Barkla DH. The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol 1978; 5:91-94. (Pubitemid 9038475)
9. Coogan PF, Strom BL, Rosenberg L. Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf 2009; 18:1111-1114.
10. Xu W, Tamim H, Shapiro S, Stang M, Collet J. Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol 2006; 7:301-308.
11. Stroup DF, Berlin JA, Morton SC, Morton SC, Olkin I, Williamson D, et al. Meta-analysis of observational studies in epidemiology. JAMA 2000; 283:2008-2012.
12. Wells GA, Shea B, Oconnel D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. Ottawa, Ontario, Canada: Ottawa Health Research Institute; 2009.
13. Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557.
14. Der Simonian R, Laird N. Meta-analysis in clinical trialset. Control Clin Trials 1986; 7:177-188.
15. Egger M, Davey Smith G, Schneider M, Christoph M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634. (Pubitemid 27387172)
16. Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer 2011; 128:227-232.
17. Cronin-Fenton D, Riis AH, Lash T, Dalton SO, Friis S, Robertson D, et al. Antidepressant use and colorectal cancer risk: a Danish population-based case-control study. Br J Cancer 2011; 104:188-192.
18. Walker A, Card T, Bates T, Muir K. Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br J Cancer 2010; 104:193-197.
19. Haukka J, Sankila R, Klaukka T, Lonnqvist J, Tanskanen A, Wahlbeck K, et al. Incidence of cancer and antidepressant medication: record linkage study. Int J Cancer 2010; 126:285-296.
20. Barkla D, Tutton P. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors. J Natl Cancer Inst 1981; 67:1207-2011.
21. Yue C, Liu Y. Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cells. Cell Biochem Funct 2005; 23:109-114. (Pubitemid 40363682)
22. Gil-Ad I, Zolokov A, Lomnitski L, Taler M, Bar M, Luria D, et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008; 33:277-286.
23. Gil-Ad I, Zolokov A, Lomnitski L, Taler M, Bar M, Luria D, et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008; 33:277-286.
24. Paulose RR, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf 2007; 16:560-570. (Pubitemid 46824278)
25. Hines-Burnham T, Novak KK, Short RM, Harmon LD, Bell WL, Schweain SL. Drugs facts and comparisons. 56th ed. St Louis: Wolters Kluwer Company. 2002; p. 929.
26. Reseland S, Bray I, Gunnell D. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br J Psychiatry 2006; 188:354.